Vaccines, biologics, adjuvant
Aeglea is committed to developing engineered human enzymes for treating rare diseases and cancers associated with abnormal amino acid metabolism.
Agenus uses the power of the immune system to develop innovative product candidates against cancer. The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and ...
Biologics. Amgen makes several therapeutic drugs that target serious disease. Many are derived from engineered monoclonal antibodies. Some target immune receptors.
A biopharmaceutical company that focuses on Cardiovascular and Metabolic diseases, Oncology, and Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal diseases, ...
Purified human proteins
Small Molecules & Biologics
Now, split in two, creating one company called Xyphos to focus on cell-based therapies for cancer and another— ...
Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative Medicine, CAR-T Immunotherapy & Cancer Treatment.
BEAT Biotherapeutics Corp. (BEATBio) is developing BB-R12, a novel gene therapy with the potential to revolutionize the treatment of heart failure.
Biocon Ltd., is committed to ensuring a global right to healthcare by addressing the worldwide need for safe, effective and affordable biotherapeutics. They are a fully-integrated ...
Small Molecules, Biologics
Bioventus is a global leader in orthobiologics. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products ...
A biopharmaceutical company. They discover, develop, and deliver medicines to treat serious disease.
Biologics, Medical Devices, Small Molecules
Small Molecules, Biologics, Vaccines, The pipeline is comprised of antibody-based therapies and other protein-based therapeutics that modulate the immune system or directly target tumors.